SectorPharmaceutical
Established Date01/03/1989
Listing Date02/04/1993
ExchangeNASDAQ Stock Exchange
Full-time Employees275
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressIconic Offices, The Greenway, Block C Ardilaun Court, 112-114 St Stephens Green, Dublin 2, Ireland
Business
IntroductionAmarin Corporation Plc was incorporated in the United Kingdom on March 1, 1989. The Company is a pharmaceutical company focused on the commercialization and development of therapies that improve cardiovascular or cardiovascular health and reduce cardiovascular risk. The company's commercialized product, VASCEPA, was first approved by the U.S., or the U.S., the Food and Drug Administration, or the U.S. FDA, as a dietary supplement to reduce triglyceride or TG levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia, or marine indications.
